• Clinical science
  • Clinician

Cerebral venous thrombosis


Cerebral venous thrombosis (CVT) is a thrombotic obstruction of the cerebral venous system that may lead to ischemic lesions (or hemorrhages) in the brain. The condition can occur in all age groups and affects women more than men, who have a higher risk of predisposing factors such as prothrombotic conditions, pregnancy, oral contraceptive use, malignancy, and infection. Headaches are a typical presenting manifestation of CVT, while focal neurological deficits, seizures, and increased intracranial pressure may develop as the disease progresses. Diagnosis is established by visualizing the cerebral veins and dural sinus with neuroimaging methods (CT and MRI with radiocontrast). Management may include treating underlying causes and neurological symptoms as well as administering systemic anticoagulation or thrombolysis. Surgical intervention in the form of direct clot lysis, recanalization or shunt placement for raised ICP, can be indicated if medical management is insufficient.


CVT, also known as cerebral venous sinus thrombosis, is a thrombotic obstruction of the cerebral veins and/or related anatomical structures (dural sinuses) which drain blood from the brain.


  • Sex: > , 3:1
  • Age of onset: ≤ 40 years
  • Prevalence: 3–4 cases per million in adults; 7 cases per million in neonates .


Epidemiological data refers to the US, unless otherwise specified.






  • Thrombogenesis occurs in the cerebral venous system, including the dural sinuses ↓ cerebral drainageintracranial pressure → clinical features; ; (see below)
  • Additionally, thrombus formation → congestion within the venous system of the brain → blood stasis → ↓ oxygenated blood in brain tissue → cerebral edema and/or infarcts/stroke


Clinical features

Since the thrombus develops gradually, clinical symptoms appear progressively and may initially fluctuate in magnitude.References:[4][3][1]


If CVT is suspected, D-dimer levels and imaging studies are first steps of diagnosis

  • D-dimers: > 500 μg/L
  • Imaging:
    • CT/MRI (with or without venography): tests of choice to confirm the diagnosis

  • Evaluation for possible causes
  • EEG: indicated if seizures are present
    • Determines seizure focus
    • May show focal abnormalities if a unilateral infarct occurs



Initial management consists of treating underlying causes, general stabilization procedures , and antithrombotic therapy, which is the mainstay of treatment for CVT. Only if there is no improvement shown with medical therapy, is surgical intervention considered.

Medical therapy

Surgical therapy

  • Indications
    • Progressive neurologic worsening (despite adequate anticoagulation)
    • Acute rise in intracranial pressure
    • Impending herniation
  • Surgical options:
    • Blood clot removal
    • Vessel recanalization
    • Shunt placement


Acute management checklist

  • 1. Alvis-miranda HR, castellar-leones SM, Alcala-cerra G, moscote-salazar LR. Cerebral sinus venous thrombosis. Journal of Neurosciences in Rural Practice. 2013; 4(4): pp. 427–38. doi: 10.4103/0976-3147.120236.
  • 2. Coutinho JM, Ferro JM, Canhão P, et al. Cerebral venous and sinus thrombosis in women. Stroke. 2009; 40(7): pp. 2356–61. doi: 10.1161/STROKEAHA.108.543884.
  • 3. McElveen WA. Cerebral Venous Thrombosis. In: Lutsep HL. Cerebral Venous Thrombosis. New York, NY: WebMD. http://emedicine.medscape.com/article/1162804. Updated September 15, 2016. Accessed December 28, 2016.
  • 4. Ferro JM, Canhão P. Etiology, clinical features, and diagnosis of cerebral venous thrombosis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/etiology-clinical-features-and-diagnosis-of-cerebral-venous-thrombosis. Last updated December 13, 2016. Accessed December 28, 2016.
  • 5. Ferro JM, Canhão P, Stam J et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004; 35(3): pp. 664–70. doi: 10.1161/01.STR.0000117571.76197.26.
  • 6. Gaillard F et al. Cerebral venous thrombosis. https://radiopaedia.org/articles/cerebral-venous-thrombosis. Updated December 28, 2016. Accessed December 28, 2016.
  • 7. Lemke DM, Hacein-Bey L. Cerebral Venous Sinus Thrombosis. In: Cerebral Venous Sinus Thrombosis. New York, NY: WebMD. http://www.medscape.com/viewarticle/514553_4. Updated January 1, 2005. Accessed December 28, 2016.
  • 8. Ferro JM, Canhão P. Treatment and prognosis of cerebral venous thrombosis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/treatment-and-prognosis-of-cerebral-venous-thrombosis. Last updated June 1, 2016. Accessed December 28, 2016.
  • 9. Saposnik G, Barinagarrementeria F, Brown RD, et al. Diagnosis and Management of Cerebral Venous Thrombosis. Stroke. 2011; 42(4): pp. 1158–1192. doi: 10.1161/str.0b013e31820a8364.
  • 10. Ferro JM, Canhão P. Acute treatment of cerebral venous and dural sinus thrombosis. Curr Treat Options Neurol. 2008; 10(2): pp. 126–137. doi: 10.1007/s11940-008-0014-0.
  • 11. Einhäupl KM, Villringer A, Mehraein S, et al. Heparin treatment in sinus venous thrombosis. The Lancet. 1991; 338(8767): pp. 597–600. doi: 10.1016/0140-6736(91)90607-q.
  • Schlossberg D. Clinical Infectious Disease. Cambridge University Press; 2015.
  • V. Lerma E, Sparks MA, Topf J. Nephrology Secrets E-Book. Elsevier Health Sciences; 2018.
  • Lin P. Treatment of Non-infectious Uveitis. Springer Nature; 2019.
  • Munjal M, Khurana AS. Fungal infections and cavernous sinus thrombosis. Indian J Otolaryngol Head Neck Surg. 2004; 56(3): pp. 235–7. doi: 10.1007/BF02974362.
  • Goldman L, Schafer AI. Goldman-Cecil Medicine E-Book. Elsevier Health Sciences; 2015.
  • David RB, MD RB. Clinical Pediatric Neurology. Demos Medical Publishing; 2009.
  • Kate MP, Thomas B, Sylaja PN. Cerebral venous thrombosis in post-lumbar puncture intracranial hypotension: case report and review of literature. F1000Res. 2014; 3: p. 41. doi: 10.12688/f1000research.3-41.v1.
  • Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis. 2018. doi: 10.1136/annrheumdis-2018-213225.
  • Ferro JM, Coutinho JM, Dentali F, et al. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis. JAMA Neurol. 2019; 76(12): p. 1457. doi: 10.1001/jamaneurol.2019.2764.
  • Ferro JM, Canhão P, Bousser M-G, Stam J, Barinagarrementeria F. Early Seizures in Cerebral Vein and Dural Sinus Thrombosis. Stroke. 2008; 39(4): pp. 1152–1158. doi: 10.1161/strokeaha.107.487363.
  • Daroff, RB; Aminoff, MJ. Encyclopedia of the Neurological Sciences. Academic Press; 2014.
  • Xu W, Gao L, Li T, Shao A, Zhang J. Efficacy and risks of anticoagulation for cerebral venous thrombosis. Medicine. 2018; 97(20): p. e10506. doi: 10.1097/MD.0000000000010506.
  • Zuurbier SM, Coutinho JM, Majoie CBLM, Coert BA, Munckhof P, Stam J. Decompressive hemicraniectomy in severe cerebral venous thrombosis: a prospective case series. J Neurol. 2011; 259(6): pp. 1099–1105. doi: 10.1007/s00415-011-6307-3.
  • Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases E-Book. Elsevier Health Sciences; 2019.
  • Reiss E, Shadomy HJ, Lyon GM. Fundamental Medical Mycology. John Wiley & Sons; 2011.
  • Martin PJ, Enevoldson TP. Cerebral venous thrombosis. Postgrad Med J. 1996; 72(844): pp. 72–76. doi: 10.1136/pgmj.72.844.72.
  • Ferro JM, Bousser M-G, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol. 2017; 24(10): pp. 1203–1213. doi: 10.1111/ene.13381.
  • Valeria Caso, Giancarlo Agnelli, Maurizio Paciaroni. Handbook on Cerebral Venous Thrombosis- Frontiers of Neurology and Neuroscience. Karger Medical and Scientific Publishers; 2005.
  • Schwartz MW. The 5 Minute Pediatric Consult. Lippincott Williams & Wilkins; 2012.
  • Sasidharan PK. Cerebral Vein Thrombosis Misdiagnosed and Mismanaged. Thrombosis. 2012; 2012: pp. 1–11. doi: 10.1155/2012/210676.
  • DENTALI F, SQUIZZATO A, MARCHESI C, BONZINI M, FERRO JM, AGENO W. D-dimer testing in the diagnosis of cerebral vein thrombosis: a systematic review and a meta-analysis of the literature. J Thromb Haemost. 2012; 10(4): pp. 582–589. doi: 10.1111/j.1538-7836.2012.04637.x.
  • Behrouzi R, Punter M. Diagnosis and management of cerebral venous thrombosis. Clin Med (Lond). 2018; 18(1): pp. 75–79. doi: 10.7861/clinmedicine.18-1-75.
  • Ferri FF. Ferri's Clinical Advisor 2015 E-Book. Elsevier Health Sciences; 2014.
  • Wasay M, Azeemuddin M. Neuroimaging of Cerebral Venous Thrombosis. Journal of Neuroimaging. 2005; 15(2): pp. 118–128. doi: 10.1111/j.1552-6569.2005.tb00296.x.
  • Stam J. Thrombosis of the Cerebral Veins and Sinuses. N Engl J Med. 2005; 352(17): pp. 1791–1798. doi: 10.1056/nejmra042354.
  • Zuurbier SM, Coutinho JM, Stam J, et al. Clinical Outcome of Anticoagulant Treatment in Head or Neck Infection–Associated Cerebral Venous Thrombosis. Stroke. 2016; 47(5): pp. 1271–1277. doi: 10.1161/strokeaha.115.011875.
  • Weerasinghe D, Lueck CJ. Septic Cavernous Sinus Thrombosis: Case Report and Review of the Literature. Neuroophthalmology. 2016; 40(6): pp. 263–276. doi: 10.1080/01658107.2016.1230138.
  • Plewa MC, Gupta M. Cavernous Sinus Thrombosis. url: https://www.ncbi.nlm.nih.gov/pubmed/28846357 Accessed March 26, 2019.
  • Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009; 49(3): pp. 325–327. doi: 10.1086/600877.
last updated 08/27/2020
{{uncollapseSections(['sJatvl', 'tJaXDl', 'FJagDl', '8JaODl', 'EJa8Dl', 'vJaADl', '9JaNwl', 'BJazwl', '-h1Dgg0'])}}